These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36843417)
1. Financial incentives for quitting smoking in pregnancy: Are they cost-effective? McMeekin N; Sinclair L; Robinson-Smith L; Mitchell A; Bauld L; Tappin DM; Boyd KA Addiction; 2023 Aug; 118(8):1445-1456. PubMed ID: 36843417 [TBL] [Abstract][Full Text] [Related]
2. Are financial incentives cost-effective to support smoking cessation during pregnancy? Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095 [TBL] [Abstract][Full Text] [Related]
3. The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Sinclair L; McFadden M; Tilbrook H; Mitchell A; Keding A; Watson J; Bauld L; Kee F; Torgerson D; Hewitt C; McKell J; Hoddinott P; Harris FM; Uny I; Boyd K; McMeekin N; Ussher M; Tappin DM; Trials; 2020 Feb; 21(1):183. PubMed ID: 32059684 [TBL] [Abstract][Full Text] [Related]
4. Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. Tappin D; Sinclair L; Kee F; McFadden M; Robinson-Smith L; Mitchell A; Keding A; Watson J; Watson S; Dick A; Torgerson D; Hewitt C; McKell J; Hoddinott P; Harris FM; Boyd KA; McMeekin N; Ussher M; Bauld L BMJ; 2022 Oct; 379():e071522. PubMed ID: 36261162 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives. van den Brand FA; Nagelhout GE; Winkens B; Chavannes NH; van Schayck OCP; Evers SMAA Addiction; 2020 Mar; 115(3):534-545. PubMed ID: 31849138 [TBL] [Abstract][Full Text] [Related]
6. A protocol for the economic evaluation of the smoking Cessation in Pregnancy Incentives Trial III (CPIT III). McMeekin N; Sinclair L; Bauld L; Tappin DM; Mitchell A; Boyd KA BMJ Open; 2020 Oct; 10(10):e038827. PubMed ID: 33109658 [TBL] [Abstract][Full Text] [Related]
7. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis. Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669 [TBL] [Abstract][Full Text] [Related]
10. Birth weight differences between those offered financial voucher incentives for verified smoking cessation and control participants enrolled in the Cessation in Pregnancy Incentives Trial (CPIT), employing an intuitive approach and a Complier Average Causal Effects (CACE) analysis. McConnachie A; Haig C; Sinclair L; Bauld L; Tappin DM Trials; 2017 Jul; 18(1):337. PubMed ID: 28728583 [TBL] [Abstract][Full Text] [Related]
11. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model. Jones M; Smith M; Lewis S; Parrott S; Coleman T Addiction; 2022 Nov; 117(11):2907-2917. PubMed ID: 35661312 [TBL] [Abstract][Full Text] [Related]
12. Study protocol of an economic evaluation embedded in the Midwives and Obstetricians Helping Mothers to Quit Smoking (MOHMQuit) trial. Pearce A; Scarfe J; Jones M; Cashmore A; Milat A; Barnes L; Passey ME BMC Health Serv Res; 2023 Sep; 23(1):939. PubMed ID: 37658343 [TBL] [Abstract][Full Text] [Related]
13. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Cooper S; Lewis S; Thornton JG; Marlow N; Watts K; Britton J; Grainge MJ; Taggar J; Essex H; Parrott S; Dickinson A; Whitemore R; Coleman T; Health Technol Assess; 2014 Aug; 18(54):1-128. PubMed ID: 25158081 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial. Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207 [TBL] [Abstract][Full Text] [Related]
15. The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial. Tappin DM; Bauld L; Tannahill C; de Caestecker L; Radley A; McConnachie A; Boyd K; Briggs A; Grant L; Cameron A; Macaskill S; Sinclair L; Friel B; Coleman T Trials; 2012 Jul; 13():113. PubMed ID: 22818493 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM Value Health; 2008; 11(2):191-8. PubMed ID: 17854434 [TBL] [Abstract][Full Text] [Related]
17. Economic analysis of financial incentives for smoking cessation during pregnancy and postpartum. Shepard DS; Slade EP; Nighbor TD; DeSarno MJ; Roemhildt ML; Williams RK; Higgins ST Prev Med; 2022 Dec; 165(Pt B):107079. PubMed ID: 35533885 [TBL] [Abstract][Full Text] [Related]
18. Financial incentives for smoking cessation in pregnancy: a single-arm intervention study assessing cessation and gaming. Ierfino D; Mantzari E; Hirst J; Jones T; Aveyard P; Marteau TM Addiction; 2015 Apr; 110(4):680-8. PubMed ID: 25727238 [TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). Essex HN; Parrott S; Wu Q; Li J; Cooper S; Coleman T Nicotine Tob Res; 2015 Jun; 17(6):636-42. PubMed ID: 25481916 [TBL] [Abstract][Full Text] [Related]
20. Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial. Berlin I; Berlin N; Malecot M; Breton M; Jusot F; Goldzahl L BMJ; 2021 Dec; 375():e065217. PubMed ID: 34853024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]